Detalhe da pesquisa
1.
Outcomes in patients with advanced urothelial carcinoma after discontinuation of programmed death (PD)-1 or PD ligand 1 inhibitor therapy.
BJU Int
; 119(4): 579-584, 2017 04.
Artigo
Inglês
| MEDLINE | ID: mdl-27700015